The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: Focus on the Deauville criteria

Haematologica

Volumn 99, Issue 6, 2014, Pages

  Quak, Elske ^a   Hovhannisyan, Narinée ^a   Lasnon, Charline ^a,b   Fruchart, Christophe ^a   Vilque, Jean Pierre ^a   Musafiri, Dada ^a   Aide, Nicolas ^a,b  

^a Haematology Institute   (France)

^b NORMANDIE UNIVERSITÉ   (France)

Author keywords

Deauville criteria; FDG PET CT; Interim PET; Non Hodgkin lymphoma; PSF reconstruction; SUV

Indexed keywords

ALGORITHM; CLINICAL PRACTICE; DATA ANALYSIS; HUMAN; LARGE CELL LYMPHOMA; LETTER; METABOLISM; MULTICENTER STUDY (TOPIC); NONHODGKIN LYMPHOMA; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; TUMOR DIAGNOSIS; LYMPHOMA, NON-HODGKIN; PROCEDURES; STANDARDS;

HUMANS; LYMPHOMA, NON-HODGKIN; POSITRON-EMISSION TOMOGRAPHY;

EID: 84901717447     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.104125     Document Type: Letter

References (11)

1. Meignan M, Gallamini A, Itti E, Barrington S, Haioun C, Polliack A. Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus. Leuk Lymphoma. 2012;53(10):1876-81.
2. Meignan M, Barrington S, Itti E, Gallamini A, Haioun C, Polliack A. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012. Leuk Lymphoma. 2014;55(1):31-7.
3. Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181-200.
4. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18FFDG PET/CT 1.0. J Nucl Med. 2006;47(5):885-95.
5. Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging. 2013;40(10):1507-15.
6. Lasnon C, Hicks RJ, Beauregard JM, Milner A, Paciencia M, Guizard AV, et al. Impact of Point Spread Function Reconstruction on Thoracic Lymph Node Staging With 18F-FDG PET/CT in Non-Small Cell Lung Cancer. Clin Nucl Med. 2012;37(10):971-6.
7. Andersen FL, Klausen TL, Loft A, Beyer T, Holm S. Clinical evaluation of PET image reconstruction using a spatial resolution model. Eur J Radiol. 2013;82(5):862-9.
8. Akamatsu G, Mitsumoto K, Taniguchi T, Tsutsui Y, Baba S, Sasaki M. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET. Eur J Radiol. 2014;83(1):226-30.
9. Lasnon C, Desmonts C, Quak E, Gervais R, Do P, Dubos-Arvis C, et al. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients. Eur J Nucl Med Mol Imaging. 2013;40(7):985-96.
10. Itti E, Juweid ME, Haioun C, Yeddes I, Hamza-Maaloul F, El Bez I, et al. Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background. J Nucl Med. 2010;51(12):1857-62.
11. Kelly MD, Declerck JM. SUVref: reducing reconstruction-dependent variation in PET SUV. EJNMMI Res. 2011;1(1):16.